SAM #RFQ133983

FDA Solicits Research on AI-Accelerated Surrogate Modeling for Cardiovascular Devices

The Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), is seeking specialized research services to advance AI-accelerated computational modeling for cardiovascular devices. - Government Buyer: - Food and Drug Administration (FDA) - Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL) - No specific Original Equipment Manufacturers (OEMs) or commercial vendors are named in the solicitation. - Requested Services: - Literature review of surrogate modeling methods for cardiovascular device applications - Development and evaluation of at least three AI-accelerated surrogate models (including neural network and Gaussian process models) for computational fluid dynamics (CFD) in cardiovascular devices - Creation of simulation datasets, code, and documentation - Assessment of decision reliability for surrogate models using a Python Jupyter notebook - Preparation of a draft journal publication summarizing methods and results - Unique/Notable Requirements: - Expertise in cardiovascular computational fluid dynamics, surrogate modeling, and regulatory science - Deliverables include datasets, code, documentation, and a draft publication - No government-furnished property or travel required - Emphasis on regulatory science and reliability assessment for AI-driven models

Description

Quantitative Decision Reliability of AI-Accelerated Computational Modeling and Simulation for Cardiovascular Devices

View original listing